Grillini, Silvia
(2025)
Mitochondrial dynamics modulation by IF1 in cancer cells and their interplay with tumor associated macrophages, [Dissertation thesis], Alma Mater Studiorum Università di Bologna.
Dottorato di ricerca in
Scienze biomediche e neuromotorie, 37 Ciclo.
Documenti full-text disponibili:
![Grillini_Silvia_tesi.pdf [thumbnail of Grillini_Silvia_tesi.pdf]](https://amsdottorato.unibo.it/style/images/fileicons/application_pdf.png) |
Documento PDF (English)
- Accesso riservato fino a 12 Febbraio 2028
- Richiede un lettore di PDF come Xpdf o Adobe Acrobat Reader
Disponibile con Licenza: Salvo eventuali più ampie autorizzazioni dell'autore, la tesi può essere liberamente consultata e può essere effettuato il salvataggio e la stampa di una copia per fini strettamente personali di studio, di ricerca e di insegnamento, con espresso divieto di qualunque utilizzo direttamente o indirettamente commerciale. Ogni altro diritto sul materiale è riservato.
Download (7MB)
| Contatta l'autore
|
Abstract
This study investigates two critical aspects of cancer cell metabolism and mitochondrial dynamics: (1) the role of the F1Fo-ATP synthase endogenous hydrolytic inhibitor IF1 in mitochondrial network organization, and (2) the metabolic interaction between neuroblastoma (NBL) cells and tumor-associated macrophages (TAMs), with a focus on the potential role of TLR8 as a microRNA receptor in this interplay. In the first analysis, we explore the function of IF1 in modulating mitochondrial fissionfusion balance, demonstrating that IF1 enhances mitochondrial network interconnection in cancer cells under stress. This may support an elevated oxidative phosphorylation rate in stress condition and may protect IF1-expressing cancer cells from apoptosis. Our findings suggest that IF1 acts as a pro-oncogenic factor, impacting mitochondrial dynamics in addition to its other tumor-promoting activities. Thus, IF1 presents a potential target for cancer therapies, with effects that may vary across different solid tumors. The second focus examines metabolic reprogramming in NBL cells co-cultured with THP-1 monocytes. Preliminary data indicate that TAMs significantly influence NBL cell metabolism, increasing their metabolic rate, potentially highlighting a pro-tumoral role of TAMs. Notably, the two NBL cell lines tested displayed diverse glucose and lactate utilization patterns, underscoring intratumorally metabolic heterogeneity. TLR8 expression in monocytes appears pivotal for this reprogramming, possibly altering the tumor microenvironment (TME) by influencing nutrient availability. Metabolic shifts in both NBL cells and TAMs suggest bidirectional reprogramming, likely proceeding in opposing metabolic directions. Future studies are needed to elucidate the precise mechanisms driving this metabolic reprogramming, potentially mediated by extracellular vesicles (EVs) and miRNAs, with TLR8 emerging as a key component in this process. This work emphasizes the value of co-culture models in cancer bioenergetics research, as they partially recapitulate the complex interactions between tumor and immune cells that are instrumental in cancer progression and metabolic adaptation.
Abstract
This study investigates two critical aspects of cancer cell metabolism and mitochondrial dynamics: (1) the role of the F1Fo-ATP synthase endogenous hydrolytic inhibitor IF1 in mitochondrial network organization, and (2) the metabolic interaction between neuroblastoma (NBL) cells and tumor-associated macrophages (TAMs), with a focus on the potential role of TLR8 as a microRNA receptor in this interplay. In the first analysis, we explore the function of IF1 in modulating mitochondrial fissionfusion balance, demonstrating that IF1 enhances mitochondrial network interconnection in cancer cells under stress. This may support an elevated oxidative phosphorylation rate in stress condition and may protect IF1-expressing cancer cells from apoptosis. Our findings suggest that IF1 acts as a pro-oncogenic factor, impacting mitochondrial dynamics in addition to its other tumor-promoting activities. Thus, IF1 presents a potential target for cancer therapies, with effects that may vary across different solid tumors. The second focus examines metabolic reprogramming in NBL cells co-cultured with THP-1 monocytes. Preliminary data indicate that TAMs significantly influence NBL cell metabolism, increasing their metabolic rate, potentially highlighting a pro-tumoral role of TAMs. Notably, the two NBL cell lines tested displayed diverse glucose and lactate utilization patterns, underscoring intratumorally metabolic heterogeneity. TLR8 expression in monocytes appears pivotal for this reprogramming, possibly altering the tumor microenvironment (TME) by influencing nutrient availability. Metabolic shifts in both NBL cells and TAMs suggest bidirectional reprogramming, likely proceeding in opposing metabolic directions. Future studies are needed to elucidate the precise mechanisms driving this metabolic reprogramming, potentially mediated by extracellular vesicles (EVs) and miRNAs, with TLR8 emerging as a key component in this process. This work emphasizes the value of co-culture models in cancer bioenergetics research, as they partially recapitulate the complex interactions between tumor and immune cells that are instrumental in cancer progression and metabolic adaptation.
Tipologia del documento
Tesi di dottorato
Autore
Grillini, Silvia
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
37
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Mitochondrial dynamics; IF1; cancer; neuroblastoma; fission; fusion; glucose, lactate; galactose; metabolic reprogramming; EVs; miRNAs; TLR8; TME; IFN-gamma; glycolysis; HCT116; 143B; THP-1; SK-N-BE(2); LAN-5; ATP synthase; MYCN; hexokinase; cristae; TAMs; OXPHOS
Data di discussione
19 Marzo 2025
URI
Altri metadati
Tipologia del documento
Tesi di dottorato
Autore
Grillini, Silvia
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
37
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
Mitochondrial dynamics; IF1; cancer; neuroblastoma; fission; fusion; glucose, lactate; galactose; metabolic reprogramming; EVs; miRNAs; TLR8; TME; IFN-gamma; glycolysis; HCT116; 143B; THP-1; SK-N-BE(2); LAN-5; ATP synthase; MYCN; hexokinase; cristae; TAMs; OXPHOS
Data di discussione
19 Marzo 2025
URI
Gestione del documento: